HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Senji Kasahara Selected Research

Cyclophosphamide (Cytoxan)

10/2018R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
6/2017CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
10/2013Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
8/2012Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.
5/2012Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
2/2012A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
9/2011Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens.
4/2011Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP.
4/2011Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma.
1/2010Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Senji Kasahara Research Topics

Disease

13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2018 - 06/2006
8Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2014 - 06/2002
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 08/2007
4Thrombocytopenia (Thrombopenia)
02/2022 - 10/2009
4Neoplasms (Cancer)
10/2020 - 02/2005
4Lymphoma (Lymphomas)
11/2016 - 06/2006
4Hematologic Neoplasms (Hematological Malignancy)
12/2014 - 03/2008
3Multiple Myeloma
10/2022 - 01/2010
3Febrile Neutropenia
02/2022 - 06/2008
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2012
3Cardiotoxicity
10/2018 - 02/2004
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2017 - 01/2009
3Leukemia
01/2010 - 06/2009
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2022 - 12/2015
2Neutropenia
02/2022 - 12/2005
2Bronchiolitis Obliterans Syndrome
12/2021 - 01/2021
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2021 - 06/2009
2Stomatitis
01/2021 - 12/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2020 - 08/2003
2Renal Insufficiency (Renal Failure)
01/2019 - 10/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2015 - 06/2011
2Primary Myelofibrosis (Myelosclerosis)
01/2011 - 08/2003
2Fever (Fevers)
11/2010 - 12/2005
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2022
1acquired Thrombotic thrombocytopenic purpura
01/2019
1Thrombotic Thrombocytopenic Purpura
01/2019
1Hemorrhage
01/2019
1Hemolytic Anemia
01/2019
1Jaundice (Icterus)
11/2016
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2015
1Pain (Aches)
12/2014
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2014
1Aspiration Pneumonia
03/2013
1Philadelphia Chromosome
06/2011
1Blast Crisis (Blast Phase)
06/2011
1Anemia
01/2011
1Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
01/2011
1Mycoses (Diseases, Fungus)
11/2010
1Hemangiosarcoma (Angiosarcoma)
01/2010

Drug/Important Bio-Agent (IBA)

14Rituximab (Mabthera)FDA Link
02/2022 - 10/2009
14Prednisolone (Predate)FDA LinkGeneric
10/2018 - 06/2002
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2018 - 06/2002
13Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 06/2002
11Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 02/2004
6pirarubicinIBA
10/2018 - 02/2004
4Etoposide (VP 16)FDA LinkGeneric
09/2017 - 06/2002
3Cytarabine (Cytosar-U)FDA LinkGeneric
02/2022 - 08/2007
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2022 - 12/2005
3Interleukin-2 Receptors (IL 2 Receptor)IBA
05/2012 - 02/2005
2Lenalidomide (CC 5013)FDA Link
10/2022 - 12/2015
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2010
2polaprezinc (Z 103)IBA
01/2021 - 12/2014
2Proteins (Proteins, Gene)FDA Link
10/2020 - 06/2006
2Carboplatin (JM8)FDA LinkGeneric
09/2017 - 06/2002
2IfosfamideFDA LinkGeneric
09/2017 - 06/2002
2MethylprednisoloneFDA LinkGeneric
09/2017 - 08/2003
2Methotrexate (Mexate)FDA LinkGeneric
09/2017 - 06/2002
2Anti-Bacterial Agents (Antibiotics)IBA
12/2015 - 03/2013
2Type II Tumor Necrosis Factor ReceptorsIBA
10/2013 - 09/2006
1Bortezomib (Velcade)FDA Link
10/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2022
1Bendamustine HydrochlorideFDA Link
02/2022
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2021
1Biological ProductsIBA
10/2020
1thiamine triphosphorate (TTP)IBA
01/2019
1SteroidsIBA
01/2019
12- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidineIBA
06/2017
1AnthracyclinesIBA
06/2017
1CytokinesIBA
12/2015
1Interleukin-1 (Interleukin 1)IBA
12/2015
1InterleukinsIBA
12/2015
1Interleukin-4 (Interleukin 4)IBA
12/2015
1Interleukin-8 (Interleukin 8)IBA
12/2015
1InterferonsIBA
04/2015
1Imatinib Mesylate (Gleevec)FDA Link
04/2015
1AlginatesIBA
12/2014
1azuleneIBA
12/2014
1SuspensionsIBA
12/2014
1Analgesics (Analgesic Drugs)IBA
12/2014
1Interleukin-18 (Interleukin 18)IBA
09/2011
1Monoclonal AntibodiesIBA
04/2011
1Prednisone (Sone)FDA LinkGeneric
04/2011
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
04/2011
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2011
1Micafungin (FK463)FDA Link
11/2010
1KynurenineIBA
04/2010
1CryoglobulinsIBA
01/2010

Therapy/Procedure

15Therapeutics
10/2022 - 06/2002
9Drug Therapy (Chemotherapy)
01/2021 - 06/2002
5Transplantation
01/2021 - 03/2008
4VAP-cyclo protocol
06/2017 - 02/2004
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2021 - 01/2010
3Hematopoietic Stem Cell Transplantation
01/2021 - 06/2009
2Platelet Transfusion (Blood Platelet Transfusions)
02/2022 - 10/2009
2Radiotherapy
11/2016 - 12/2014
2Aftercare (After-Treatment)
03/2013 - 10/2009
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021
1Plasma Exchange
01/2019
1Chemoradiotherapy
12/2014
1Induction Chemotherapy
06/2011